FDA consults on SUDs (single use devices) labelling
This article was originally published in Clinica
Executive Summary
The US FDA last week asked for help in sorting out an unresolved issue regarding its regulatory scheme for reprocessed single use devices (SUDs): that of how to handle mention of the original equipment manufacturer (OEM) in the labelling.